Knuff & Co LLC Purchases 68 Shares of Danaher Co. (NYSE:DHR)

Knuff & Co LLC increased its position in shares of Danaher Co. (NYSE:DHR) by 0.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,258 shares of the conglomerate’s stock after acquiring an additional 68 shares during the period. Knuff & Co LLC’s holdings in Danaher were worth $2,296,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Legal & General Group Plc increased its stake in shares of Danaher by 2.4% in the second quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate’s stock valued at $1,490,112,000 after buying an additional 139,989 shares during the period. Capital Research Global Investors grew its holdings in Danaher by 1.0% during the 1st quarter. Capital Research Global Investors now owns 5,125,470 shares of the conglomerate’s stock worth $1,279,932,000 after acquiring an additional 52,679 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Danaher by 2.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,398,649 shares of the conglomerate’s stock valued at $849,195,000 after acquiring an additional 85,081 shares during the period. Massachusetts Financial Services Co. MA raised its stake in shares of Danaher by 22.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate’s stock valued at $761,475,000 after acquiring an additional 563,546 shares during the last quarter. Finally, Swedbank AB acquired a new position in shares of Danaher during the first quarter worth $676,545,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. The trade was a 18.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Stock Down 0.4 %

DHR stock opened at $229.50 on Tuesday. The stock’s 50 day simple moving average is $261.33 and its 200 day simple moving average is $260.45. The company has a market cap of $165.76 billion, a P/E ratio of 43.80, a price-to-earnings-growth ratio of 4.24 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher Co. has a fifty-two week low of $207.63 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the prior year, the firm earned $2.02 earnings per share. On average, research analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is currently 20.61%.

Analyst Ratings Changes

A number of analysts recently weighed in on DHR shares. Stephens restated an “overweight” rating and issued a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Wells Fargo & Company started coverage on Danaher in a research report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price objective for the company. Evercore ISI upped their target price on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Barclays decreased their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Finally, Leerink Partners boosted their price target on shares of Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.